ME/CFS South Australia Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
ME/CFS South Australia Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
Medical Marijuana Great For Migraine, Fibromyalgia And Irritable Bowel Syndrome, Survey Finds
Saturday 28 November 2015
From the National Pain Report:
Medical Marijuana Great for Migraine, Fibromyalgia and Irritable Bowel Syndrome, Survey Finds
One-hundred percent (100%) of people with migraine headache, fibromyalgia or irritable bowel syndrome who use medical marijuana for a minimum of 30 days report a reduction in pain and discomfort, a survey of 621 by the Care By Design found.
People included in the survey suffer from a range of different conditions, and some suffer from multiple conditions, including:
Cannabis and Well-Being
“A majority of patients (88.2%) reported that cannabis therapy improved their overall sense of wellbeing,” the study found. “Patients with fibromyalgia, headaches and migraines, PTSD and anxiety reported the greatest improvement in general wellbeing (as compared to other patient groups).”
Cannabis and Pain
“A majority of all patients (72.6%) reported a decrease in pain or discomfort. All patients (100%) with headaches and migraines, fibromyalgia, irritable bowel syndrome (IBS), and spinal cord injury reported a decrease in pain or discomfort. Less than 1% of patients reported an increase in pain or discomfort after CBD-rich cannabis therapy. (All patients reporting an increase in pain reported using CBD for ALS.)”
Cannabis and Mood
“A majority of all patients (64.2%) reported an improvement in mood. All patients (100%) with PTSD and spinal cord injuries reported an improvement in mood. Some patients with sleep problems (8%) and cancer (3%) reported a worsening of mood. While a majority of patients taking CBD-rich cannabis for “general wellbeing” rather than for a specific medical condition reported improved mood (66.7%), this group was also the most likely to report a worsening of mood (16.7%).”
Cannabis and Energy Levels
Half of all patients (50.4%) reported no change in energy level. The patients most likely to report increased energy levels were those with inflammation (64.0%), fibromyalgia (57.1%), and PTSD (55.6%). Patients with headaches or migraines were the most likely to report reduced energy levels (37.5%).
The survey was conducted by Care by Design, which sells CBD cannabis sprays, oils and vape cartridges, so the survey has some weaknesses. A high percentage of survey participants (42%) reported that they did not know the ratio of CBD-to-THC they were taking.
“This report represents preliminary data based on less than one thousand patients. It is not meant to provide patients with guidance on dosing or medical treatment. Rather, it is meant to suggest possible areas for additional research.”
The above, with comments, originally appeared here.
blog comments powered by Disqus
Registered Charity 3104
PO Box 322,
South Australia 5092
1300 128 339
Monday - Friday,
10am - 4pm